Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Identification of cardioprotective drugs by medium-scale in vivo pharmacological screening on a Drosophila cardiac model of Friedreich's ataxia.

Palandri A, Martin E, Russi M, Rera M, Tricoire H, Monnier V.

Dis Model Mech. 2018 Jul 20;11(7). pii: dmm033811. doi: 10.1242/dmm.033811.

2.

Anti-glycan antibodies halt axon regeneration in a model of Guillain Barrè Syndrome axonal neuropathy by inducing microtubule disorganization via RhoA-ROCK-dependent inactivation of CRMP-2.

Rozés Salvador V, Heredia F, Berardo A, Palandri A, Wojnacki J, Vivinetto AL, Sheikh KA, Caceres A, Lopez PH.

Exp Neurol. 2016 Apr;278:42-53. doi: 10.1016/j.expneurol.2016.01.016. Epub 2016 Jan 22.

PMID:
26804001
3.

A Yeast/Drosophila Screen to Identify New Compounds Overcoming Frataxin Deficiency.

Seguin A, Monnier V, Palandri A, Bihel F, Rera M, Schmitt M, Camadro JM, Tricoire H, Lesuisse E.

Oxid Med Cell Longev. 2015;2015:565140. doi: 10.1155/2015/565140. Epub 2015 Oct 11.

4.

Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways.

Palandri A, Salvador VR, Wojnacki J, Vivinetto AL, Schnaar RL, Lopez PH.

Cell Death Dis. 2015 Sep 3;6:e1876. doi: 10.1038/cddis.2015.228.

5.

Frataxin inactivation leads to steroid deficiency in flies and human ovarian cells.

Palandri A, L'hôte D, Cohen-Tannoudji J, Tricoire H, Monnier V.

Hum Mol Genet. 2015 May 1;24(9):2615-26. doi: 10.1093/hmg/ddv024. Epub 2015 Jan 26.

PMID:
25628335
6.

Methylene blue rescues heart defects in a Drosophila model of Friedreich's ataxia.

Tricoire H, Palandri A, Bourdais A, Camadro JM, Monnier V.

Hum Mol Genet. 2014 Feb 15;23(4):968-79. doi: 10.1093/hmg/ddt493. Epub 2013 Oct 8.

PMID:
24105471

Supplemental Content

Loading ...
Support Center